Rosenblatt Rates Five9 (FIVN) buy, $29 Price Target

Rosenblatt has reaffirmed its buy rating on FIVN, setting a price target of $29. This update came on June 24, 2026, as analyst Catharine Trebnick maintained her optimistic view on the company's potential.

Other Institutional Activity in FIVN

There has been notable activity among institutional investors regarding FIVN. BlackRock, Inc. trimmed its stake by 319,027 shares, leaving it with 7,047,642 shares valued at approximately $106.9 million. Vanguard Portfolio Management LLC initiated a new position, acquiring 6,719,982 shares worth about $101.9 million. Voss Capital, LP slightly reduced its holdings by 70,000 shares to 5,825,000 shares, valued at around $88.4 million. Van Berkom & Associates Inc. also reduced its stake by 263,244 shares, resulting in 3,333,136 shares valued at approximately $50.6 million. Meanwhile, Vanguard Capital Management LLC opened a new position with 3,329,054 shares, valued at about $50.5 million.

Five9, Inc. Stock Down 40.0%

Shares of FIVN traded near $19.06 on Wednesday. The stock has seen various insider transactions recently, with several executives selling shares. Chief Financial Officer Lee Bryan sold 1,511 shares at an average price of $24.25 on June 5, 2026, under a planned sale. President Andy Dignan also sold shares on the same date, with a total of 3,073 shares at the same price, also planned. Additionally, Chief Revenue Officer Matthew Tuckness sold 8,645 shares at $24.81 on June 4, 2026.

Analysts Set New Price Targets

On June 24, 2026, Rosenblatt maintained its buy rating for FIVN with a price target of $29. Other analysts have also weighed in recently. On May 1, 2026, UBS maintained a buy rating with a $25 target, while DA Davidson held a hold rating with a $22 target. Piper Sandler reiterated a hold rating with a $24 target, and Needham reaffirmed a buy rating with a $40 target.

Bottom Line

Rosenblatt's reaffirmation of its buy rating for FIVN with a $29 target suggests continued confidence in the company's prospects. Institutional activity shows varied interest, with some funds reducing their positions while others, like Vanguard, are initiating new stakes. While insider selling could raise eyebrows, it is often part of planned transactions. Investors should remember that analyst ratings and 13F filings reflect past decisions and may not indicate current sentiment.